Cure Pharmaceutical Holding - Delisted Pink Sheet
Cure Pharmaceutical Holding is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Cure Pharmaceutical was actively traded.
Valuation
Check how we calculate scores
Cure Pharmaceutical Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cure Pharmaceutical market risk premium is the additional return an investor will receive from holding Cure Pharmaceutical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cure Pharmaceutical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cure Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Cure Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 11.2 | |||
| Semi Deviation | 11.73 | |||
| Standard Deviation | 17.75 | |||
| Variance | 315.16 |
Cure Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cure Pharmaceutical pink sheet to make a market-neutral strategy. Peer analysis of Cure Pharmaceutical could also be used in its relative valuation, which is a method of valuing Cure Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cure Pharmaceutical Corporate Directors
Cure Pharmaceutical corporate directors refer to members of a Cure Pharmaceutical board of directors. The board of directors generally takes responsibility for the Cure Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Cure Pharmaceutical's board members must vote for the resolution. The Cure Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Gene Salkind | Director | Profile | |
| Ruben KingShaw | Director | Profile | |
| William Yuan | Director | Profile | |
| Lauren Chung | Director | Profile |
Still Interested in Cure Pharmaceutical Holding?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Cure Pink Sheet
If you are still planning to invest in Cure Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cure Pharmaceutical's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |